Cargando…
Group 3 pulmonary hypertension: Challenges and opportunities
Autores principales: | McGettrick, Michael, Peacock, Andrew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Magdi Yacoub Heart Foundation
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7590933/ https://www.ncbi.nlm.nih.gov/pubmed/33150151 http://dx.doi.org/10.21542/gcsp.2020.6 |
Ejemplares similares
-
Predicting Group II pulmonary hypertension: diagnostic accuracy of the H2FPEF and OPTICS scores in Scotland
por: Stubbs, Harrison, et al.
Publicado: (2022) -
Social deprivation in Scottish populations with pulmonary hypertension secondary to connective tissue disease and chronic thromboembolic disease
por: McGettrick, Michael, et al.
Publicado: (2020) -
Shared mechanisms of multimorbidity in COPD, atherosclerosis and type-2 diabetes: the neutrophil as a potential inflammatory target
por: Hughes, Michael J., et al.
Publicado: (2020) -
Drug repositioning in pulmonary arterial hypertension: challenges and opportunities
por: Grinnan, Daniel, et al.
Publicado: (2019) -
Synovial tissue biopsy analysis: unlocking the hidden secrets to personalised medicine?
por: McGettrick, Helen Michelle
Publicado: (2019)